Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended March 31, 2023.

This press release features multimedia. View the full release here:... | May 10, 2023

Related Keywords

United States ,United Kingdom ,Ukraine ,Japan ,Israel ,Canada ,China ,Brazil ,Russia ,America ,Richard Francis ,Natco Pharma Ltd ,International Markets Profit ,Us Department Of Justice ,International Markets Segment ,Europe Or International ,Teva Pharmaceutical Industries Ltd ,European Union ,International Markets Gross Profit ,Our International ,Teva Pharmaceutical Industries ,International Markets ,North America ,Segment Revenues ,Major Products ,Natco Pharma ,Pharmaceutical Industries ,Private Securities Litigation Reform Act ,Sherman Act ,Quarterly Report ,Annual Report ,Looking Statements ,Teva Pharmaceutical Industries Limited Stock Exchange ,News ,Information ,Press Release ,Eva ,Harmaceutical ,Industries ,Oday ,Eported ,Results ,Or ,The ,Quarter ,Nded ,Arch ,Dress ,Release ,Features ,View ,Bull ,Elease Teva Us8816242098 ,